ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 159

Interleukin-18 as a Key Cytokine to Understand Pathology and to Decide Appropriate Therapeutic Strategy in Chronic Arthritic Systemic Juvenile Idiopathic Arthritis

Takako Miyamae1, Yumi Tani 1, Manabu Kawamoto 2, Takayuki Kishi 3 and Masayoshi Harigai 2, 1Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women's Medical University, TOKYO, Japan, 3Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: cytokines, innate immunity, Systemic JIA, Transition

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Session Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Long-term outcomes of systemic JIA are highly variable. approximately half of the patients have chronic persistent arthritis requiring extended anti-inflammatory therapy, sometimes into adulthood. However, pathology of the chronic arthritic sJIA has not been fully understood whereas early acute febrile sJIA is driven by innate immune mechanisms. The purpose of this study is to evaluate the pro-inflammatory cytokine profile and therapeutic response in patients with chronic arthritic sJIA. 

Methods: Patients with acute febrile sJIA, chronic arthritic sJIA, and polyarticular JIA or rheumatoid arthritis were included in this study. Chronic arthritic sJIA was defined as the condition of persistent arthritis lack of systemic inflammation such as fever and skin rash for more than 6 months or the condition of persistent arthritis lack of systemic inflammation under the treatment of tocilizumab, anti-IL-6 receptor monoclonal antibody, without glucocorticoid. Serum samples were obtained from the individuals during the active phase. The serum concentrations of IL-18, IL-6, and calprotectin, a complex of the proteins S100 A8 and S100 A9, were evaluated using commercial enzyme-linked immunosorbent assays according to the manufacturer’s instructions. Intra-group comparisons were performed using the Mann–Whitney test or Fisher’s exact probability test, where appropriate. A p value of < 0.05 was considered to indicate a significant difference. Responses to disease modifying antirheumatic drugs were reviewed from medical records.

Results: Four patients with acute febrile sJIA, 12 with chronic arthritic sJIA, and 9 with polyarticular JIA or rheumatoid arthritis were enrolled. The serum IL-18 levels in patients with chronic arthritic sJIA (1,597.6 ± 1,793.2 pg/mL) were significantly lower than those in patients with acute febrile sJIA (26,799.9 ± 24568.3 pg/mL; p < 0.05) and significantly higher than those in patients with pJIA/RA (264.3 ± 72.4 pg/mL; p < 0.05). In the comparison of chronic arthritic sJIA and polyarticular JIA/RA, both calprotectin and IL-6 showed higher in chronic arthritic sJIA, but there were no significant differences. Seven patients with serum IL-18 level under 1,000 pg/mL (488.9±247.2 pg/mL) in chronic arthritic sJIA were successfully treated by conventional medication such as NSAIDs and/or methotrexate whereas the other group with IL-18 level over 1,000 pg/mL (3205.6±1791.8 pg/mL) required tocilizumab. 

Conclusion: Albeit a small number of patients, this study indicated that serum IL-18 levels vary in patients with chronic arthritic sJIA. IL-18 may serve as a key cytokine to estimate whether the pathology of the patient is more likely driven by innate or acquired immunity and to guide into appropriate therapeutic strategy.

Serum IL_18 levels in patients with acute febrile sJIA, chronic arthritic sJIA, and polyarticular JIA/RA. Bars indicate median values. Statistically significant differences between each patient group are indicated as follows: ⁎p < 0.05.

Serum profiles of IL_18 and Calprotectin in patients with acute febrile sJIA, chronic arthritic sJIA, and polyarticular JIA/RA.


Disclosure: T. Miyamae, None; Y. Tani, None; M. Kawamoto, None; T. Kishi, None; M. Harigai, None.

To cite this abstract in AMA style:

Miyamae T, Tani Y, Kawamoto M, Kishi T, Harigai M. Interleukin-18 as a Key Cytokine to Understand Pathology and to Decide Appropriate Therapeutic Strategy in Chronic Arthritic Systemic Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/interleukin-18-as-a-key-cytokine-to-understand-pathology-and-to-decide-appropriate-therapeutic-strategy-in-chronic-arthritic-systemic-juvenile-idiopathic-arthritis/. Accessed April 16, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interleukin-18-as-a-key-cytokine-to-understand-pathology-and-to-decide-appropriate-therapeutic-strategy-in-chronic-arthritic-systemic-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.